These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 20206438

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
    Gour J, Edwards R, Lemieux S, Ghassemi M, Jog M, Duval C.
    Brain Res Bull; 2007 Sep 14; 74(1-3):66-74. PubMed ID: 17683791
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levodopa-induced dyskinesias detection based on the complexity of involuntary movements.
    Chelaru MI, Duval C, Jog M.
    J Neurosci Methods; 2010 Jan 30; 186(1):81-9. PubMed ID: 19878692
    [Abstract] [Full Text] [Related]

  • 5. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
    Fenney A, Jog MS, Duval C.
    Clin Neurol Neurosurg; 2008 Feb 30; 110(2):160-7. PubMed ID: 18063471
    [Abstract] [Full Text] [Related]

  • 6. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
    Cerasa A, Salsone M, Morelli M, Pugliese P, Arabia G, Gioia CM, Novellino F, Quattrone A.
    Parkinsonism Relat Disord; 2013 Oct 30; 19(10):883-8. PubMed ID: 23769805
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.
    Barbin L, Leux C, Sauleau P, Meyniel C, Nguyen JM, Pereon Y, Damier P.
    Parkinsonism Relat Disord; 2013 Feb 30; 19(2):165-70. PubMed ID: 23000298
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dyskinesia-induced postural instability in Parkinson's disease.
    Armand S, Landis T, Sztajzel R, Burkhard PR.
    Parkinsonism Relat Disord; 2009 Jun 30; 15(5):359-64. PubMed ID: 18851925
    [Abstract] [Full Text] [Related]

  • 15. Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks.
    Liu X, Carroll CB, Wang SY, Zajicek J, Bain PG.
    J Neurosci Methods; 2005 May 15; 144(1):47-52. PubMed ID: 15848238
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.
    Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, Dellapina E, Destée A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, Sommet A, Viallet F, Vidailhet M, Rascol O, NS-Park CIC Network.
    Neurology; 2014 Jan 28; 82(4):300-7. PubMed ID: 24371304
    [Abstract] [Full Text] [Related]

  • 18. Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.
    LeWitt PA.
    Mov Disord; 1998 Jul 28; 13(4):731-4. PubMed ID: 9686783
    [Abstract] [Full Text] [Related]

  • 19. Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks.
    Keijsers NL, Horstink MW, Gielen SC.
    Mov Disord; 2003 Jan 28; 18(1):70-80. PubMed ID: 12518302
    [Abstract] [Full Text] [Related]

  • 20. Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.
    Cerasa A, Pugliese P, Messina D, Morelli M, Gioia MC, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.
    Mov Disord; 2012 Mar 28; 27(3):364-71. PubMed ID: 22076870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.